AUR-105 by Aurigene Oncology for Leukemia: Likelihood of Approval

AUR-105 is under clinical development by Aurigene Oncology and currently in Phase I for Leukemia.

Phone use at night worsens sleep and mental health in kids, especially cyberbullying victims

The impact of nighttime phone use on sleep and mental health is significant, with cyberbullying intensifying psychological distress in children and adolescents.

September 6, 2024

Study sheds new light on how obesity affects fat cells’ mitochondria

The number of people with obesity has nearly tripled since 1975, resulting in a worldwide epidemic. While lifestyle factors like diet and exercise play a

January 29, 2024

Open-access atlas unveils the molecular mechanisms of roundworm aging

A new aging atlas gives scientists an in-depth view of how individual cells and tissues in worms age and how different lifespan-extending strategies might stop

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.